TTM Technologies
TTMI
128.20
-4.51
-3.40%
TTM Technologies
US · TTMI
#1247 by market cap
Listed 1970
128.20
-4.51
-3.40%
Live - 5344 symbols - heartbeat 112s ago
· 2026-10-08 06:43
Pre-market
124.44
-2.93%
After-hours
128.98
+0.61%
Overnight
126.00
-1.72%
- Market cap
- 13.51B
- P/E (TTM)i
- 57.75
- P/Bi
- 6.98
- EPSi
- 1.68
- Div yieldi
- 0.00%
- 52W posi
- 44%
Reader sentiment
Are you bullish or bearish on TTMI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.54, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +18.98% YoY
Margins
- Gross margin
- 20.70%
- Operating margin
- 9.21%
- Net margin
- 6.11%
Key ratios & quality
- Enterprise valuei
- 13.93B
- PEG ratioi
- 2.47
- Altman Z-Scorei
- 5.54
PEG uses trailing P/E against the 3-year net income growth rate (23.33%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.24B | 2.13B | 2.11B | 2.25B | 2.50B | 2.23B | 2.44B | 2.91B |
| Gross profit | 402.67M | 377.18M | 359.02M | 372.01M | 457.97M | 413.27M | 477.38M | 601.69M |
| Selling & admin expenses | 208.34M | 198.46M | 186.36M | 187.88M | 233.36M | 226.55M | 250.14M | 277.61M |
| Research & development | 13.72M | 17.94M | 19.77M | 18.15M | 24.81M | 27.27M | 31.85M | 28.99M |
| Operating profit | 123.63M | 115.01M | 114.06M | 130.24M | 162.70M | 110.77M | 159.84M | 267.53M |
| Pretax profit | 47.19M | 34.33M | -46.28M | 70.05M | 182.86M | 297.00K | 83.95M | 210.34M |
| Tax | -88.21M | 2.41M | -29.89M | 15.64M | 88.28M | 19.02M | 27.65M | 32.89M |
| Net profit | 173.58M | 41.30M | 177.54M | 54.41M | 94.58M | -18.72M | 56.30M | 177.45M |
| Basic EPS | 2 | 0 | 2 | 1 | 1 | 0 | 1 | 2 |
| Diluted EPS | 1.38 | 0.39 | 1.67 | 0.50 | 0.91 | -0.18 | 0.54 | 1.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 648.67M | 730.62M | 752.74M | 774.32M | 845.98M | 1.00B |
| Gross profit | 130.97M | 148.11M | 156.74M | 165.87M | 181.18M | 211.86M |
| Selling & admin expenses | 65.05M | 71.04M | 70.39M | 71.14M | 93.74M | 87.60M |
| Research & development | 8.06M | 7.01M | 7.04M | 6.88M | 7.81M | 7.98M |
| Operating profit | 50.97M | 63.18M | 72.42M | 80.97M | 72.75M | 109.40M |
| Pretax profit | 40.99M | 45.53M | 61.81M | 62.01M | 58.53M | 81.25M |
| Tax | 8.81M | 4.00M | 8.76M | 11.32M | 8.54M | -1.80M |
| Net profit | 32.18M | 41.53M | 53.06M | 50.69M | 49.99M | 83.05M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 1 |
| Diluted EPS | 0.31 | 0.40 | 0.50 | 0.48 | 0.47 | 0.77 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.21B | 1.34B | 1.25B | 1.41B | 1.49B | 1.43B | 1.61B | 1.86B |
| Cash & ST investments | 256.36M | 379.82M | 451.57M | 537.68M | 402.75M | 450.21M | 503.93M | 501.23M |
| Inventory | 109.38M | 113.75M | 115.65M | 127.61M | 170.64M | 213.08M | 224.99M | 250.06M |
| Total assets | 3.46B | 3.56B | 2.90B | 3.03B | 3.32B | 3.32B | 3.47B | 3.84B |
| Total current liabilities | 673.21M | 946.67M | 518.05M | 558.15M | 761.33M | 703.98M | 809.05M | 962.20M |
| Short-term debt | 30.00M | 249.98M | 8.14M | 6.36M | 57.37M | 11.93M | 11.35M | 12.72M |
| Long-term debt | 1.46B | 1.23B | 842.85M | 927.82M | 879.41M | 914.34M | 914.36M | 912.34M |
| Total liabilities | 2,230,416,000.00 | 2,281,896,000.00 | 1,451,935,000.00 | 1,570,130,000.00 | 1,788,025,000.00 | 1,812,624,000.00 | 1,908,670,000.00 | 2,078,078,000.00 |
| Total equity | 1.23B | 1.28B | 1.44B | 1.46B | 1.54B | 1.51B | 1.56B | 1.76B |
| Retained earnings | 433.01M | 474.31M | 651.84M | 706.26M | 800.84M | 782.12M | 838.42M | 1.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.58B | 1.68B | 1.76B | 1.86B | 1.91B | 2.25B |
| Cash & ST investments | 411.26M | 447.97M | 491.12M | 501.23M | 410.05M | 507.91M |
| Inventory | 246.84M | 250.34M | 253.69M | 250.06M | 280.21M | 307.97M |
| Total assets | 3.45B | 3.58B | 3.72B | 3.84B | 3.98B | 4.42B |
| Total current liabilities | 764.54M | 827.75M | 905.20M | 962.20M | 1.02B | 1.26B |
| Short-term debt | 11.72M | 12.10M | 12.14M | 12.72M | 14.08M | 13.99M |
| Long-term debt | 913.85M | 913.34M | 912.84M | 912.34M | 911.84M | 969.46M |
| Total liabilities | 1,867,598,000.00 | 1,941,036,000.00 | 2,019,080,000.00 | 2,078,078,000.00 | 2,143,369,000.00 | 2,481,281,000.00 |
| Total equity | 1.59B | 1.64B | 1.70B | 1.76B | 1.84B | 1.93B |
| Retained earnings | 870.60M | 912.13M | 965.19M | 1.02B | 1.07B | 1.15B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 273.14M | 311.94M | 287.18M | 176.63M | 272.87M | 187.28M | 236.89M | 291.88M |
| Depreciation & amortization | 225.73M | 219.87M | 166.13M | 127.33M | 133.91M | 160.73M | 150.13M | 147.17M |
| Free cash flow | 123.01M | 169.36M | 183.89M | 94.68M | 169.99M | 27.04M | 51.16M | -683.00K |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 0 | -64.73M | -35.42M | -24.43M | -34.48M | -17.88M |
| Ending cash balance | 256.36M | 400.15M | 451.57M | 537.68M | 402.75M | 450.21M | 503.93M | 501.23M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -10.66M | 97.80M | 141.80M | 62.93M | 21.74M | 96.43M |
| Depreciation & amortization | 36.09M | 36.92M | 36.81M | 37.36M | 38.52M | 40.35M |
| Free cash flow | -73.97M | 37.40M | 42.35M | -6.46M | -85.11M | 34.07M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -17.88M | 0 | 0 | 0 | 0 | 0 |
| Ending cash balance | 411.26M | 447.97M | 491.12M | 501.23M | 410.05M | 507.91M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 15.51 | 3.30 | 13.04 | 3.75 | 6.32 | -1.23 | 3.66 | 10.67 |
| ROA %i | 5.56 | 1.18 | 5.50 | 1.84 | 2.98 | -0.56 | 1.66 | 4.85 |
| ROIC %i | 9.82 | 4.22 | 9.57 | 3.79 | 5.22 | 0.68 | 3.45 | 8.03 |
| 5-year avg ROE %i | 6.40 | 6.65 | 9.93 | 9.83 | 8.38 | 5.04 | 5.11 | 4.64 |
| EBIT margin %i | 5.93 | 4.81 | 1.28 | 5.14 | 9.15 | 2.17 | 5.38 | 8.80 |
| FCF / sales %i | 4.32 | 6.30 | 8.73 | 4.21 | 6.81 | 1.21 | 2.09 | -- |
| Current ratioi | 1.79 | 1.42 | 2.41 | 2.52 | 1.96 | 2.03 | 1.99 | 1.93 |
| Quick ratioi | 1.59 | 1.20 | 2.13 | 2.24 | 1.68 | 1.65 | 1.65 | 1.59 |
| Debt / assetsi | 43.16 | 41.88 | 29.98 | 31.85 | 28.96 | 30.68 | 29.24 | 26.78 |
| LT debt / equityi | 119.18 | 97.06 | 59.56 | 65.78 | 58.95 | 66.70 | 64.19 | 57.64 |
| Interest coveragei | 2.14 | 1.55 | 0.37 | 2.54 | 5.02 | 1.01 | 2.77 | 5.64 |
| Revenue CAGR (3Y) %i | 2.21 | -5.57 | -7.48 | 0.16 | 5.36 | 1.98 | 2.80 | 5.22 |
| Net income CAGR (3Y) %i | -- | 5.81 | 12.64 | -32.07 | 31.81 | -- | 1.14 | 23.33 |
| FCF CAGR (3Y) %i | -3.65 | -7.39 | 0.45 | -8.36 | 0.12 | -47.22 | -18.55 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.02 | 5.89 | 8.12 | 10.67 | 11.40 | 13.26 |
| ROA %i | 2.31 | 2.69 | 3.70 | 4.85 | 5.25 | 5.92 |
| ROIC %i | 4.31 | 4.87 | 6.34 | 8.03 | 8.50 | 9.69 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.25 | 6.48 | 7.43 | 8.80 | 8.77 | 9.10 |
| FCF / sales %i | -- | 0.67 | 1.29 | -- | -- | -- |
| Current ratioi | 2.07 | 2.03 | 1.94 | 1.93 | 1.88 | 1.78 |
| Quick ratioi | 1.68 | 1.65 | 1.59 | 1.59 | 1.52 | 1.44 |
| Debt / assetsi | 29.52 | 28.72 | 27.56 | 26.78 | 26.36 | 24.98 |
| LT debt / equityi | 63.51 | 62.04 | 59.55 | 57.64 | 56.33 | 56.31 |
| Interest coveragei | 3.38 | 3.76 | 4.68 | 5.64 | 6.12 | 7.01 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial is the largest reported line at 61.91% of revenue, across 3 reported segments.
- Aerospace and Defense (A&D) follows at 38.12%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial61.91%
Aerospace and Defense (A&D)38.12%
Quote time 2026-10-08 06:43:06 · For reference only, not investment advice and not tailored to your situation.